| scholarly article | Q13442814 |
| P2093 | author name string | Castillo M | |
| Kwock L | |||
| Smith JK | |||
| P433 | issue | 9 | |
| P304 | page(s) | 1645-1649 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | American Journal of Neuroradiology | Q15762571 |
| P1476 | title | Correlation of myo-inositol levels and grading of cerebral astrocytomas | |
| P478 | volume | 21 |
| Q43790888 | 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. |
| Q30655700 | Advanced MR imaging of gliomas: an update |
| Q34369508 | Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade |
| Q92103981 | Advanced imaging in adult diffusely infiltrating low-grade gliomas |
| Q36429012 | Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls |
| Q38244225 | Applying metabolomics to understand the aggressive phenotype and identify novel therapeutic targets in glioblastoma |
| Q64263608 | Assessment of Overall Survival in Glioma Patients as Predicted by Metabolomic Criteria |
| Q35085539 | Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. |
| Q40361769 | Brain tumor evaluation and segmentation by in vivo proton spectroscopy and relaxometry |
| Q33681165 | Can diffusion tensor metrics help in preoperative grading of diffusely infiltrating astrocytomas? A retrospective study of 36 cases. |
| Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
| Q34793308 | Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. |
| Q34549715 | Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T. |
| Q33678281 | Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma |
| Q36367172 | Current Clinical Brain Tumor Imaging |
| Q34320362 | Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target |
| Q37409750 | Diagnosing relapse in children's brain tumors using metabolite profiles |
| Q52725603 | Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons. |
| Q48103905 | Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics |
| Q39402126 | Early prediction of response to Vorinostat in an orthotopic rat glioma model |
| Q38269055 | Epilepsy associated tumors: Review article |
| Q34992526 | Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM |
| Q40160872 | Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers |
| Q30836527 | Fast spectroscopic multiple analysis (FASMA) for brain tumor classification: a clinical decision support system utilizing multi-parametric 3T MR data |
| Q37024727 | High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors |
| Q33657683 | Imaging of brain tumors: MR spectroscopy and metabolic imaging |
| Q27002499 | Imaging tumor metabolism using in vivo magnetic resonance spectroscopy |
| Q33720190 | In vivo mapping of brain myo-inositol |
| Q58613996 | Increased right amygdala metabolite concentrations in the absence of atrophy in children and adolescents with PTSD |
| Q33753445 | Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas |
| Q35171890 | Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas |
| Q31148126 | MR Spectroscopy to Distinguish between Supratentorial Intraventricular Subependymoma and Central Neurocytoma |
| Q31113788 | MR spectroscopy in brain tumors |
| Q26751140 | Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors |
| Q48399316 | Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. |
| Q37425085 | Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders |
| Q39172977 | Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype? |
| Q36560256 | Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome. |
| Q37010991 | Metabolism of diffuse intrinsic brainstem gliomas in children |
| Q38961858 | Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information |
| Q36406413 | Metabolomic signature of brain cancer |
| Q36208989 | Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma |
| Q33888867 | Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis |
| Q88746661 | Microfluidics in Malignant Glioma Research and Precision Medicine |
| Q27002344 | Modern brain tumor imaging |
| Q37225057 | Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas |
| Q92794895 | Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement |
| Q35675400 | Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat model |
| Q47967307 | Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma. |
| Q36235508 | Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. |
| Q42936756 | Neurochemical metabolites in the medial prefrontal cortex in bipolar disorder: A proton magnetic resonance spectroscopy study |
| Q35775001 | Neuromorphometry of primary brain tumors by magnetic resonance imaging |
| Q37183615 | Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels |
| Q39656462 | Preoperative proton-MR spectroscopy of gliomas--correlation with quantitative nuclear morphology in surgical specimen |
| Q90655712 | Prospective multicentre evaluation and refinement of an analysis tool for magnetic resonance spectroscopy of childhood cerebellar tumours |
| Q46190703 | Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses |
| Q31103164 | Proton MRS imaging in pediatric brain tumors |
| Q26828606 | Recent advances in the application of metabolomics to Alzheimer's Disease |
| Q30831591 | Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels |
| Q55461993 | Spectroscopic evaluation of glioma grading at 3T: the combined role of short and long TE. |
| Q30958322 | Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value |
| Q46529453 | The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours |
| Q30838169 | Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor |
| Q26865120 | Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches |
Search more.